Fluifort 10 Granulated Sachets 2.75 gr

€11.50
Tax included
Minsan
023834118
100% secure payments
Hurry up! Only 40 item(s) left in Stock!
Quantity

WARNINGS
There are no known phenomena of addiction or dependence. The drug does not affect low-calorie or controlled diets and can also be administered to diabetic patients. It does not contain gluten; therefore it can be administered to patients with celiac disease. Contains aspartame as a sweetener: this substance is contraindicated in subjects suffering from phenylketonuria. Dissolve the contents of the sachet in about half a glass of water, stirring well.
PHARMACOTHERAPEUTIC CATEGORY
Preparations for cough and colds; expectorants excluded associations with cough suppressants, mucolytics.
STORAGE
This medicine does not require any special storage conditions.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients. Gastroduodenal ulcer. Pregnancy and breastfeeding. The drug is contraindicated in pediatric patients (under 11 years).
NAME
FLUIFORT 2.7 G GRANULES FOR ORAL SOLUTION
EXCIPIENTS
Citric acid, mannitol, povidone, natural cedar flavor, natural orange flavor, orange juice, aspartame, maltodextrin.
SIDE EFFECTS
Skin, subcutaneous tissue disorders: skin rash, urticaria, erythema, exanthema, bullous rash / erythema, pruritus, angioedema, dermatitis. Gastrointestinal disorders: abdominal pain, nausea, vomiting, diarrhea. Nervous system disorders: dizziness. Respiratory, thoracic and mediastinal disorders: dyspnoea. Vascular disorders: redness.
PREGNANCY AND BREASTFEEDING
Although the active ingredient is neither teratogenic nor mutagenic and has not shown negative effects on reproductive function in animals, the drug should not be administered during pregnancy. Since no data are available on the passage of carbocysteine lysine salt monohydrate into breast milk, use during lactation is contraindicated.
INDICATIONS
Mucolytic, fluidifying in acute and chronic respiratory diseases.
INTERACTIONS
In controlled clinical studies, no interactions have been shown with the most common drugs used in the treatment of upper and lower respiratory tract diseases, nor with food and with laboratory tests.
DOSAGE
1 sachet a day. In consideration of the pharmacokinetic characteristics, the recommended posology can be maintained even in patients with renal and hepatic insufficiency. Duration of treatment: carbocysteine lysine salt monohydrate can also be used for prolonged periods, in this case it is advisable to follow the doctor's advice. Instructions for using the sachet: dissolve the contents of the sachet in about half a glass of water, stirring well.
ACTIVE PRINCIPLES
1 sachet of 5 g contains: carbocysteine lysine salt monohydrate equal to 2.7 g of carbocysteine lysine salt.
023834118
40 Items

Specific References

chat Comments (0)
No customer reviews for the moment.

Fluifort 10 Granulated...

€11.50